Little Green Pharma (ASX:LGP) Debt-to-Equity

: 0.07 (As of Sep. 2023)

View and export this data going back to 2020. Start your Free Trial

Little Green Pharma's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2023 was A$2.72 Mil. Little Green Pharma's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2023 was A$3.05 Mil. Little Green Pharma's Total Stockholders Equity for the quarter that ended in Sep. 2023 was A$80.70 Mil. Little Green Pharma's debt to equity for the quarter that ended in Sep. 2023 was 0.07.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Little Green Pharma's Debt-to-Equity or its related term are showing as below:

ASX:LGP' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.02 Med: 0.12 Max: 0.14
Current: 0.07

During the past 4 years, the highest Debt-to-Equity Ratio of Little Green Pharma was 0.14. The lowest was 0.02. And the median was 0.12.

ASX:LGP's Debt-to-Equity is ranked better than
77.16% of 858 companies
in the Drug Manufacturers industry
Industry Median: 0.29 vs ASX:LGP: 0.07

Little Green Pharma Debt-to-Equity Historical Data

The historical data trend for Little Green Pharma's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Little Green Pharma Annual Data

Trend

Jun19

Jun20

Jun21

Mar23

Debt-to-Equity

0.14

0.02

0.14

Little Green Pharma Semi-Annual Data
	Jun20	Dec20	Jun21	Dec21	Mar23	Sep23
Debt-to-Equity		0.11	0.02	0.14	0.14	0.07

Competitive Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Little Green Pharma's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Little Green Pharma Debt-to-Equity Distribution

For the Drug Manufacturers industry and Healthcare sector, Little Green Pharma's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Little Green Pharma's Debt-to-Equity falls into.

Little Green Pharma Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Little Green Pharma's Debt to Equity Ratio for the fiscal year that ended in Mar. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(6.556	+	5.312)	/	82.228
	=	0.14

Little Green Pharma's Debt to Equity Ratio for the quarter that ended in Sep. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(2.721	+	3.046)	/	80.695
	=	0.07

Little Green Pharma (ASX:LGP) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Little Green Pharma Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Little Green Pharma's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Little Green Pharma (ASX:LGP) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Little Green Pharma Ltd (ASX:LGP) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

66 Kings Park Road, Level 2, Suite 2, West Perth, Perth, WA, AUS, 6005

Website

https://www.littlegreenpharma.com

Little Green Pharma Ltd is engaged in the vertically integrated medicinal cannabis business. The business activities of the company include cultivation, production, research and development, manufacturing, and distribution of medicinal cannabis products. The company's two key types of products available at Little Green Pharma are oils (which are ingested) and flowers (which are usually inhaled through vaporizing). The company offers LGP-branded medicinal cannabis oil products in the Australian and European markets.

Little Green Pharma (ASX:LGP) Headlines

No Headlines